Immunity to tuberculosis: A delicate balance between protection and pathology

FEMS Immunology and Medical Microbiology

Volumn 23, Issue 2, 1999, Pages 149-158

  Ehlers, Stefan ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Chronic inflammation; Granuloma formation; Hypersensitivity; Immunopathology; T cell mediated immunity; Tuberculosis

Indexed keywords

BCG VACCINE;

ANIMAL MODEL; BACTERIAL INFECTION; CONFERENCE PAPER; GRANULOMA; IMMUNITY; IMMUNOPATHOLOGY; INFECTION PREVENTION; LUNG INFECTION; MOUSE; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY; TUBERCULOSIS;

EID: 0032967118     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(98)00130-8     Document Type: Conference Paper

References (69)

1. Raviglione, M.C., Snider, D.E. and Kochi, A. (1995) Global epidemiology of tuberculosis. J. Am. Med. Assoc. 273, 220-226.
2. Bloom, B.R. and Fine, P.E.M. (1994) The BCG experience: implications for future vaccines against tuberculosis. In: Tuberculosis: Pathogenesis, Protection, and Control (Bloom, B.R., Ed.), pp. 531-557. ASM Press, Washington, DC.
3. Roche, P.W., Triccas, J.A. and Winter, N. (1995) BCG vaccination against tuberculosis: past disappointments and future hopes. Trends Microbiol. 3, 397-401.
4. Huygen, K., Cpontent, J., Denis, O., Montgomery, D.L., Yawman, A.M., Deck, R.R., DeWitt, C., Orme, I.M., Baldwin, S., D'Souza, C.D., Drowart, A., Lozes, E., Vandenbussche, P., Van Vooren, J.-P., Liu, M.A. and Ulmer, J.B. (1996) Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2, 893-898.
5. Orme, I.M., Andersen, P. and Boom, W. (1994) T cell responses to Mycobacterium tuberculosis. J. Infect. Dis. 167, 1481-1484.
6. Szalay, G. and Kaufmann, S.H.E. (1996) Basic principles of immunity against intracellular bacteria and protozoa. In: Concepts in Vaccine Design (Kaufmann, S.H.E., Ed.), pp. 117-140. Walter de Gruyter, Berlin.
7. Chan, J. and Kaufmann, S.H.E. (1994) Immune mechanisms of protection. In: Tuberculosis: Pathogenesis, Protection and Control (Bloom, B.R., Ed.), pp. 389-416. ASM Press, Washington, DC.
8. Cooper, A.M. and Flynn, J.L. (1995) The protective immune response to Mycobacterium tuberculosis. Curr. Opin. Immunol. 7, 512-516.
9. Cooper, A.M., Saunders, B.M., D'Souza, C.D., Frank, A.A. and Orme, I.M. (1997) Mycobacterium tuberculosis-driven processes in gene-disrupted mice. Bull. Inst. Pasteur 95, 85-96.
10. Ehlers, S., Mielke, M.E.A. and Hahn, H. (1994) Progress in TB research: Robert Koch's dilemma revisited. Immunol. Today 15, 1-4.
11. Appelberg, R., Castro, A.G., Pedrosa, J. and Minoprio, P. (1994) Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice. Immunology 82, 361-364.
12. Flesch, I.E. and Kaufmann, S.H.E. (1990) Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 58, 2675-2677.
13. Ladel, C.H., Blum, C., Dreher, A., Reifenberg, K., Kopf, M. and Kaufmann, S.H.E. (1997) Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect. Immun. 65, 4843-4849.
14. Flynn, J.L., Goldstein, M.M., Chan, J., Triebold, K.J., Pfeffer, K., Lowenstein, C.J., Schreiber, R., Mak, T.W. and Bloom, B.R. (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2, 561-572.
15. Cooper, A.M., Magram, J., Ferrante, J. and Orme, I.M. (1997) IL-12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186, 39-45.
16. Cooper, A.M., Dalton, D.K., Stewart, T.A., Griffin, J.P., Russell, D.G. and Orme, I.M. (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178, 2243-2247.
17. Flynn, J.L., Chan, J., Triebold, K.J., Dalton, D.K., Stewart, T.A. and Bloom, B.R. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249-2254.
18. Bancroft, G.J. (1993) The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 5, 503-510.
19. Rhoades, E.R., Cooper, A.M. and Orme, I.M. (1995) Chemokine response in mice infected with Mycobacterium tuberculosis. Infect. Immun. 63, 3871-3877.
20. Muller, I., Cobbold, S.P., Waldmann, H. and Kaufmann, S.H.E. (1987) Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect. Immun. 55, 2037-2041.
21. Leveton, C., Barnass, S., Champion, B., Lucas, S., De Souza, B., Nicol, M., Banerjee, D. and Rook, G. (1989) T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect. Immun. 57, 390-395.
22. Ladel, C.H., Blum, C., Dreher, A., Reifenberg, A. and Kaufmann, S.H.E. (1995) Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur. J. Immunol. 25, 2877-2881.
23. Orme, I.M. (1993) The role of CD8+ T cells in immunity to tuberculosis infection. Trends Microbiol. 1, 77-78.
24. Flynn, J.L., Goldstein, M.M., Triebold, K.J., Koller, B., and Bloom, B.R. (1992) Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89, 12013-12017.
25. Izzo, A.A. and North, R.J. (1992) Evidence for an αβ T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guérin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells. J. Exp. Med. 176, 581-586.
26. D'Souza, C.D., Cooper, A.M., Frank, A.A., Mazzaccaro, R.J., Bloom, B.R. and Orme, I.M. (1997) An anti-inflammatory role for γδ T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J. Immunol. 158, 1217-1221.
27. Stenger, S., Mazzaccaro, R.J., Uyemura, K., Cho, S., Barnes, P.F., Rosat, J.P., Sette, A., Brenner, M.B., Porcelli, S.A., Bloom, B.R. and Modlin, R.L. (1997) Differential effects of cytolytic T cell subsets on intracellular infection. Science 276, 1684-1687.
28. Oddo, M., Renno, T., Attinger, A., Bakker, T., MacDonald, H.R. and Meylan, P.R. (1998) Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 160, 5448-5454.
29. Nathan, C.F. (1986) Interferon gamma and macrophage activation in cell mediated immunity. In: Mechanisms of Host Resistance to Infectious Agents, Tumours and Allografts (Steimann, R.M. and North, R.J., Eds.), pp. 165-184. Rockefeller University Press, New York, NY.
30. Orme, I.M., Roberts, A.D., Griffin, J.P. and Abrams, J.S. (1993) Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151, 518-525.
31. MacMicking, J., North, R., LaCourse, R., Mudgett, J., Shah, S. and Nathan, C.F. (1997) Identification of NOS2 as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94, 5243-5248.
32. Schaible, U.E., Sturgill-Koszycki, S., Schlesinger, P.H. and Russell, D.G. (1998) Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol. 160, 1290-1296.
33. Chan, J., Xing, Y., Magliozzo, R. and Bloom, B.R. (1992) Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175, 1111-1122.
34. Chan, J., Tanaka, K., Carroll, D., Flynn, J.L. and Bloom, B.R. (1995) Effects of nitric oxide inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63, 736-740.
35. Tascon, R.E., Stavropoulos, E., Lukacs, K.V. and Colston, M.J. (1998) Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect. Immun. 66, 830-834.
36. Cooper, A.M., D'Souza, C.D., Frank, A.A. and Orme, I.M. (1997) The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect. Immun. 65, 1317-1320.
37. Stenger, S., Hanson, D.A., Teitelbaum, R., Dewan, P., Niazi, K.R., Froelich, C.J., Ganz, T., Thoma-Uszynski, S., Melian, A., Bogdan, C., Porcelli, S.A., Bloom, B.R., Krensky, A.M. and Modlin, R.L. (1998) An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282, 121-125.
38. North, R.J. (1995) Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route. J. Infect. Dis. 172, 1550-1553.
39. Dunn, P.L. and North, R.J. (1995) Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect. Immun. 63, 3428-3437.
40. Wayne, L.G. (1994) Dormancy of Mycobacterium tuberculosis and latency of disease. Eur. J. Clin. Microbiol. Infect. Dis. 13, 908-914.
41. Orme, I.M. (1988) A mouse model of the recrudescence of latent tuberculosis in the elderly. Am. Rev. Respir. Dis. 137, 716-718.
42. Glatman-Freedman, A. and Casadevall, A. (1998) Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin. Microbiol. Rev. 11, 514-532.
43. Vordermeier, H.M., Venkataprasad, N., Harris, D.P. and Ivanyi, J. (1996) Increase of tuberculous infection in the organs of B cell-deficient mice. Clin. Exp. Immunol. 106, 312-316.
44. Campos-Neto, A., Ovendale, P., Bement, T., Koppi, T.A., Fanslow, W.C., Rossi, M.A. and Alderson, M.R. (1998) CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J. Immunol. 160, 2037-2041.
45. Rook, G. A., and Hernandez-Pando, R. (1994) T cell helper types and endocrines in the regulation of tissue-damaging mechanism in tuberculosis. Immunobiology 191, 478-492.
46. North, R.J. (1998) Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin. Exp. Immunol. 113, 55-58.
47. Rook, G.A.W. and Bloom, B.R. (1994) Mechanisms of pathogenesis in tuberculosis. In: Tuberculosis: Pathogenesis, Protection and Control (Bloom, B.R., Ed.), pp. 485-502. ASM Press, Washington, DC.
48. Jagirdar, J. and Zagzag, D. (1996) Pathology and insights into pathogenesis of tuberculosis. In: Tuberculosis (Rom, W.N. and Garay, S., Eds.), pp. 467-482. Little, Brown and Co., Boston, MA.
49. Dannenberg, A.M. Jr. and Rook, G.A.W. (1994) Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses - dual mechanisms that control bacillary multiplication. In: Tuberculosis: Pathogenesis, Protection, and Control (Bloom, B.R., Ed.), pp. 459-483. American Society for Microbiology, Washington, DC.
50. Hänsch, H.C.R., Smith, D.A., Mielke, M.E.A., Hahn, H., Bancroft, G.J. and Ehlers, S. (1996) Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. Int. Immunol. 8, 1299-1310.
51. Smith, D.A., Hänsch, H.C.R., Bancroft, G.J. and Ehlers, S. (1997) T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma. Immunology 92, 413-421.
52. King, P.D., Sandberg, E.T., Selvakumar, A., Fang, P., Beaudet, A.L. and Dupont, B. (1995) Novel isoforms of murine intercellular adhesion molecule-1 generated by alternative RNA splicing. J. Immunol. 154, 6080-6093.
53. Johnson, C.M., Cooper, A.M., Frank, A.A. and Orme, I.M. (1998) Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene. Infect. Immun. 66, 1666-1670.
54. Lu, B., Rutledge, B.J., Gu, L., Fiorillo, J., Lukacs, N.W., Kunkel, S.L., North, R., Gerard, C. and Rollins, B.J. (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187, 601-608.
55. Boring, L., Gosling, J., Chensue, S.W., Kunkel, S.L., Farese, R.V., Broxmeyer, H.E. and Charo, I.F. (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine response in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100, 2552-2561.
56. Rhoades, E.R., Frank, A.A. and Orme, I.M. (1997) Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tubercle Lung Dis. 78, 57-66.
57. Toossi, Z. and Ellner, J.J. (1998) The role of TGF beta in the pathogenesis of human tuberculosis. Clin. Immunol. Immunopathol. 87, 107-114.
58. Kindler, V., Sappino, A.-P., Grau, G., Piguet, P.-F. and Vassalli, P. (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56, 731-740.
59. McMurray, D.N. (1994) Guinea pig model of tuberculosis. In: Tuberculosis: Pathogenesis, Protection and Control (Bloom, B.R., Ed.), pp. 135-148. ASM Press, Washington, DC.
60. Converse, P.J., Dannenberg, A.M. Jr., Estep, J.E., Sugisaki, K., Abe, Y., Schofield, B.H. and Pitt, M.L.M. (1996) Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli. Infect. Immun. 64, 4776-4787.
61. Orme, I.M. (1988) Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J. Immunol. 140, 3589-3593.
62. Cooper, A.M., Callahan, J.E., Keen, M., Belisle, J.T., and Orme, I.M. (1997) Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tubercle Lung Dis. 78, 67-73.
63. Orme, I.M. and Collins, F.M. (1983) Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients. J. Exp. Med. 158, 74-83.
64. Orme, I.M. (1987) The kinetics of emergence and loss of mediator T lymphocytes in response to infection with Mycobacterium tuberculosis. J. Immunol. 138, 293-297.
65. Murray, P.J., Aldovini, A. and Young, R.A. (1996) Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines. Proc. Natl. Acad. Sci. USA 93, 934-939.
66. Andersen, P. (1997) Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand. J. Immunol. 45, 115-131.
67. Lindblad, E.B., Elhay, M.J., Silva, R., Appelberg, R. and Andersen, P. (1997) Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect. Immun. 65, 623-629.
68. Andersen, P., Andersen, A.B., Sorensen, A.L. and Nagai, S. (1995) Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154, 3359-3372.
69. Baldwin, S.L., D'Souza, C.D., Roberts, A.D., Kelly, B.P., Frank, A.A., Lui, M.A., Ulmer, J.B., Huygen, K., McMurray, D.M. and Orme, I.M. (1998) Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66, 2951-2959.